XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Tax Matters (Tables)
9 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets and liabilities

Significant components of the Company’s deferred tax assets and liabilities as of September 30, 2022, and December 31, 2021, were as follows:

​

​

​

​

​

​

​

​

(In thousands)

    

September 30, 2022

    

December 31, 2021

Deferred tax assets:

 

​

  

 

​

  

Loss carryforwards

​

$

2,235

​

$

2,244

Capitalized costs

​

 

91

​

 

127

Stock option granted

​

​

1,001

​

​

1,060

Policy acquisition costs

​

​

5,705

​

​

3,640

Charitable contribution carryforward

​

​

—

​

​

—

General business credits

​

​

6

​

​

6

Derivative option allowance

​

​

—

​

​

510

Sec 163(j) limitation

​

​

173

​

​

171

Benefit reserves

​

 

10,871

​

 

6,720

Property and equipment

​

​

73

​

​

33

Impairments

​

​

403

​

​

—

Unrealized losses on investments

​

​

14,049

​

​

—

Other

​

​

1,464

​

​

1,464

Total deferred tax assets

​

 

36,071

​

 

15,975

Less valuation allowance

​

 

(31,363)

​

 

(14,431)

Total deferred tax assets, net of valuation allowance

​

 

4,708

​

 

1,544

Deferred tax liabilities:

​

 

  

​

 

  

Unrealized losses on investments

​

 

—

​

 

1,084

Intangible assets

​

 

147

​

 

147

Derivative option allowance

​

 

3,810

​

 

—

Bond Discount

​

​

751

​

​

313

Property and equipment

​

 

—

​

 

—

Total deferred tax liabilities

​

 

4,708

​

 

1,544

Net deferred tax assets

​

$

—

​

$

—

Schedule of effective tax rate reconciliation

There was income tax expense of $1.3 million and tax benefit of $0.4 million for the three months ended September 30, 2022, and 2021, respectively. There was income tax expense of $3.8 million and $1.8 million for the nine months ended September 30, 2022, and 2021, respectively. This differed from the amounts computed by applying the statutory U.S. federal income tax rate of 21% to pretax income, as a result of the following:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended September 30, 

​

Nine months ended September 30, 

(In thousands)

    

2022

    

2021

    

2022

    

2021

Computed expected income tax benefit (expense)

​

$

(796)

​

$

749

​

$

(2,305)

​

$

1,676

Reduction (increase) in income taxes resulting from:

​

 

​

​

 

  

​

 

​

​

 

  

IMR and reinsurance

​

​

176

​

​

65

​

​

158

​

​

240

Nondeductible expenses

​

​

(3)

​

​

1

​

​

(8)

​

​

4

Change in valuation allowance

​

 

(641)

​

 

333

​

 

(1,693)

​

​

3,266

Dividends received deduction

​

​

—

​

​

(1)

​

​

—

​

​

(6)

Deferred tax adjustment

​

​

14

​

​

—

​

​

—

​

​

—

Subtotal of increases

​

 

(454)

​

 

398

​

 

(1,543)

​

 

3,504

Tax benefit (expense)

​

$

(1,250)

​

$

351

​

$

(3,848)

​

$

(1,828)